Martin Godbout, Chair of the Board, is pleased to announce the appointment of three new members to the G\u00e9nome Qu\u00e9bec Board of Directors. The Board team is proud to have the support of high-calibre professionals with experience in varied fields, including finance, agrifood and the pharmaceutical industry.<\/p>\n
\u00a0<\/p>\n
Fran\u00e7ois R. Roy<\/strong>\u00a0has extensive experience as a corporate director and executive in the public and private sectors, on boards of various non-profit organizations and in academia. He has worked for the Soci\u00e9t\u00e9 g\u00e9n\u00e9rale de financement du Qu\u00e9bec and subsequently as Chief Financial Officer for Qu\u00e9becor, Avenor and Telemedia Corporation. He has also served on boards of directors since 1998 and currently sits on the board of Transcontinental, Noranda Income Fund, Capstone Infrastructure Corporation, Ovivo Inc. and the Caisse de d\u00e9p\u00f4t et placement du Qu\u00e9bec. From 2007 to 2010, he was the Chief Financial Officer at McGill University. Mr. Roy holds a Master of Business Administration.<\/p>\n Suzanne Vinet<\/strong>\u00a0launched her public service career in 1984 at Agriculture and Agri-Food Canada, where she gained extensive experience in strategic and trade policy. In recent years, she has held several senior positions, including Deputy Minister at Agriculture and Agri-Food Canada (2012-2014), President at Canada Economic Development for Qu\u00e9bec Regions (2010-2012) and Associate Deputy Minister at Health Canada (2007-2009). Ms. Vinet holds a Bachelor of Arts (economics).<\/p>\n Dr. Brian White-Guay<\/strong>, a medical specialist by training, joined the pharmaceutical industry in 1984 as Director of Clinical Research, first for Ayerst in Montr\u00e9al then, in 1986, for Merck Frosst in Kirkland.\u00a0In 1992, he was named Merck\u2019s Vice President of Regulatory Affairs for Europe, in Brussels. Then in 2004, he served as Merck\u2019s Vice President responsible for all clinical operations and medical departments located around the world. He joined the Faculty of Pharmacy at Universit\u00e9 de Montr\u00e9al as a professor in 2008 and has been a member of AmorChem\u2019s Investment Committee since 2011.\u00a0<\/span><\/p>\n The arrival of these new members on the G\u00e9nome Qu\u00e9bec Board of Directors constitutes an asset that will help accelerate the discovery of new applications in the strategic sectors of health, forestry, the environment and agrifood. \u201cWe want to be on the cutting edge of what is happening in genomic research in Qu\u00e9bec and Canada. The recruitment of such qualified, seasoned professionals will certainly go a long way toward helping us reach that goal. We are fortunate to be able to count on Board Members with such significant expertise and knowledge,\u201d Martin Godbout said.\u00a0<\/p>\n For the complete listing of G\u00e9nome Qu\u00e9bec Board Members:\u00a0www.genomequebec.com\/en\/management-board.html<\/a><\/p>\n